Curie.Bio
Wenyan Miao is a seasoned biopharmaceutical professional with extensive experience in immunology and biochemistry. Currently serving as the VP of the CSO Partner Team at Curie.Bio since June 2024, Wenyan has previously held senior leadership roles, including VP of Immunology at ROME Therapeutics and VP of Immunology & Inflammation at Celsius Therapeutics. Experience also includes significant positions such as Executive Director of Immunology at Nimbus Therapeutics and Senior Director of Molecular and Cell Biology at Repligen Corp. Wenyan's early career featured roles at Pfizer Inc., Abbott Bioresearch Center, Millennium Pharmaceuticals, and LeukoSite, culminating in a postdoctoral fellowship. Wenyan earned a PhD in Biochemistry and Molecular Biology from Indiana University School of Medicine.
This person is not in the org chart
This person is not in any teams
Curie.Bio
2 followers
Curie.Bio is a founder-focused seed-stage venture firm combined with an industry-grade therapeutics accelerator focused on one thing: helping entrepreneurial founders launch viable therapeutics companies. Curie.Bio does this by giving founders access to a team of the world’s best drug hunters and drug makers, seed capital, and best-of-breed services - everything a founder needs to get from concept to a compelling quality dataset that enables an awesome Series A financing. In a nutshell, we want founders in control of their own company and focused on their area of expertise and creativity, while we help make the rest happen smoothly.